. 2016 Feb 22;100(Suppl 3):S19–S26. doi: 10.1097/TP.0000000000001096
Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially.
TABLE 1.
Registry analyses and meta-analyses of CMVIG prophylaxis
